Matches in Wikidata for { <http://www.wikidata.org/entity/Q66080069> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q66080069 description "clinical trial" @default.
- Q66080069 description "ensayu clínicu" @default.
- Q66080069 description "klinisch onderzoek" @default.
- Q66080069 description "клінічне випробування" @default.
- Q66080069 description "կլինիկական փորձարկում" @default.
- Q66080069 name "Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan" @default.
- Q66080069 name "Safety Assessment of Lyxumia" @default.
- Q66080069 type Item @default.
- Q66080069 label "Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan" @default.
- Q66080069 label "Safety Assessment of Lyxumia" @default.
- Q66080069 prefLabel "Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan" @default.
- Q66080069 prefLabel "Safety Assessment of Lyxumia" @default.
- Q66080069 P1050 Q66080069-2DA10B5A-47DB-4C04-A26F-F54C242F89E1 @default.
- Q66080069 P1132 Q66080069-D4A48C2C-16EF-4903-95DC-E956F828E9C8 @default.
- Q66080069 P1476 Q66080069-C53E7FEF-003D-4EB5-9BEC-033AAD0C8982 @default.
- Q66080069 P17 Q66080069-513EA70A-7126-41E2-8AC7-DB99B743795B @default.
- Q66080069 P17 Q66080069-74AF4A39-40AB-4FA9-9642-42937567AD1B @default.
- Q66080069 P17 Q66080069-837A9C3A-DF72-47D4-9650-F3F9CEF4B842 @default.
- Q66080069 P17 Q66080069-DDA19BDA-8907-4085-BB68-B8FB830AFDC0 @default.
- Q66080069 P1813 Q66080069-21BBC026-61FD-4B00-8F3C-8C9BE04ABBCE @default.
- Q66080069 P2899 Q66080069-DC7B1555-2499-47D7-ADF5-0E7E3BF2A82A @default.
- Q66080069 P3098 Q66080069-A67BE015-49DC-4D6E-AFF8-DB7C06A6D88C @default.
- Q66080069 P31 Q66080069-07DE59BB-AC2A-4970-871A-3794928D3B57 @default.
- Q66080069 P4844 Q66080069-16079F86-79AD-4217-8E69-8F34EE2C771D @default.
- Q66080069 P4844 Q66080069-8ED3F9D3-58F7-4D52-B672-115A181440D9 @default.
- Q66080069 P580 Q66080069-A0EE643D-371D-443B-9B17-21FB43DE20D8 @default.
- Q66080069 P582 Q66080069-09AAA37C-3394-4FB0-A12A-62694060F076 @default.
- Q66080069 P6099 Q66080069-4B7BF5CA-44CE-4C3E-AD41-0F39159EA785 @default.
- Q66080069 P8363 Q66080069-5171F0B5-F552-4804-9E86-464A1CC9AAA2 @default.
- Q66080069 P1050 Q12206 @default.
- Q66080069 P1132 "+184" @default.
- Q66080069 P1476 "International, Randomized, Open Label Study to Compare the Safety and Efficacy of Lixisenatide vs. Sulfonylurea on Top of Basal Insulin Treatment in Type 2 Diabetes Mellitus Subjects Who Elect to Fast During Ramadan" @default.
- Q66080069 P17 Q43 @default.
- Q66080069 P17 Q668 @default.
- Q66080069 P17 Q801 @default.
- Q66080069 P17 Q817 @default.
- Q66080069 P1813 "LixiRam" @default.
- Q66080069 P2899 "+18" @default.
- Q66080069 P3098 "NCT02941367" @default.
- Q66080069 P31 Q30612 @default.
- Q66080069 P4844 Q19484 @default.
- Q66080069 P4844 Q6659956 @default.
- Q66080069 P580 "2017-02-23T00:00:00Z" @default.
- Q66080069 P582 "2017-08-04T00:00:00Z" @default.
- Q66080069 P6099 Q42825046 @default.
- Q66080069 P8363 Q78089383 @default.